期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Endoglin基因在妊娠期高血压疾病胎盘中的表达及意义 被引量：1

Expression and significance of Endoglin gene in placenta of hypertensive disorders complicating pregnancy
原文传递
导出
摘要 目的探讨妊娠期高血压疾病患者胎盘组织中Endoglin基因水平的变化及临床意义。方法选择2010年8月至2011年4月在北京军区总医院住院分娩的妊娠期高血压疾病患者共44例(妊娠期高血压疾病组),其中妊娠期高血压孕妇15例(妊娠期高血压组),轻度子痫前期孕妇14例(轻度子痫前期组),重度子痫前期孕妇15例(重度子痫前期组);以同期正常晚期妊娠孕妇16例为对照组。采用实时定量RT-PCR检测各组孕妇胎盘组织中Endoglin mRNA表达水平。结果妊娠高血压疾病组患者胎盘组织中Endoglin mRNA相对表达量明显高于对照组,差异有统计学意义(P<0.05);轻度子痫前期组、重度子痫前期组患者胎盘组织中Endoglin mRNA相对表达量均明显高于对照组,差异有统计学意义(P均<0.05)。结论 Endoglin在妊娠期高血压疾病患者尤其是轻度子痫前期及重度子痫前期患者胎盘中高度表达,其表达水平可能与病情的发生发展密切相关。 Objective： To explore changes of Endoglin gene in placenta of hypertensive disorders complicating pregnancy and its clinical significance. Methods： From Aug 2010 to Apr 2011, 44 patients with hypertensive disorders complicating pregnancy （HDCP） who delivered in General Hospital of Beijing Military Command were recruited in the study group （ HDCP group）, including 15 women with gestational hypertension （GH group）, 14 women with moderate preeclampsia （MPE Group） and 15 women with severe preeclampsia （ SPE group）. Another 16 healthy pregnant women were taken as control group. Quantitative Real Time RT - PCR was used to investigate the expression of Endoglin mRNA in placenta. Results ： the expression of Endoglin mRNA in the placenta of HDCP group were significantly elevated than that in control group （P 〈 0. 05 ）. The expression of Endoglin mRNA in GH group, MPE group and SPE group were gradually increased. The expression of Endoglin mRNA in placenta of MPE group and SPE group were both obviously higher than that of control group （ P 〈 0. 05 ）. Conclusions ： The expression of Endoglin is significantly increased in placenta in HDCP, especially MPE and SPE. The rising level may be closely related with the occurrence and development of disease.
作者 杨彩霞 王晶 尚丽新
机构地区 山西医科大学 北京军区总医院
出处 《中国优生与遗传杂志》 2012年第8期23-25,共3页 Chinese Journal of Birth Health & Heredity
基金 国家自然科学基金(81050001)
关键词 子痫前期 ENDOGLIN 胎盘 Preeclampsia Endoglin Placenta
分类号 R714.25 [医药卫生—妇产科学]
  • 相关文献

参考文献15

  • 1Rana S, Karumanchi SA, Richard J, et al. Sequential changes in anti- angiogenic factors in early pregnancy and risk of developing pre- eclampsia[J]. Hypertension,2007,50:137 -142.
  • 2Cheifetz S, Bellon T,Cales C,et al. Endoglin is a component of the transforming growth factor - beta receptor system in human endothelial cells[ J]. J Biol Chem,1992,267 (27):19027 - 19030.
  • 3Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contrib- utes to the pathogenesis of preeclampsia[ J ]. Nat Med,2006,12 (6) : 642 - 649.
  • 4Gu Y,Lewis DF,W ang Y. Placental productions and expressions of soluble endoglin, soluble fms - like tyrosine kinase receptor - 1, and placental growth factor in normal and preeclamptic pregnancies [ J ]. JC1 in Endocriol Metab ,2008,93 ( 1 ) : 260 - 266.
  • 5Staff AC, Braekke K, Johnsen GM, et al. Circulating concentrations of soluble endoglin ( CD105 ) in fetal and maternal serum and in amniot- ic fluid in preeclampsia [ J ]. Am J Obstet Gynecol, 2007,2 ( 197 ) : 176.
  • 6Farina A, Sekizawa A, De Sanctis R, et al. Gene expression in chori-onic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat Diagn,2008,28 (10) : 956 - 960.
  • 7Gilbert JS, Gilbert SA, Arany M, et al. Hypertension produced by pla- cental ischemia in pregnant rats is associated with increased soluble Endoglin expression[ J]. Hypertension,2009,53 (2) : 399 -403.
  • 8Fonsatti E, Ahomonte M, Nicotra MR, et al. Endoglin ( CD105 ) : a powerful therapeutic target on tumor - associated angiogenetic blood- vessels[J]. Oncogene.2003.22 (42) : 6557 - 6563.
  • 9Levine R J, Lam C, Qian C, et al. Soluble endoglin and other circulat- ing antiang iogenic factors in preeclampsia [ J ]. N Engl J Med, 2006,355( 10):992.
  • 10Ziemssen F, Wegner R, Wegner J, et al. Analysis of neovascu lature in uvealmelanoma by targeting the TGF - 13 binding receptor endog- lin:is there prognostic relevance of proliferating endothelium [ J ]. Graefes Arch Clin Exp Ophthalmo, [ J ] 2006,244 ( 9 ) : 1124 - 1131.

二级参考文献7

  • 1Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Bio- chem Pharmacol 2008; 75(2): 346-359.
  • 2Zhu YC (朱毓纯), Sun Y, Yang HX, Liao QP. Profile of se- rum soluble endoglin in pregnant women with severe pre-ec- lampsia and eclampsia. Chin J Obstet Gynecol (中华妇产科杂志) 2009; 44:91-93 (Chinese, English abstract).
  • 3Li FJ (李富军), Wang XP, Liu B, Li Y, Li J. Culture of hu- man trophoblast cells from first trimester placentae of human origin. J Fourth Mil Med Univ (第四军医大学学报) 2004;25(24): 2261-2263 (Chinese, English abstract).
  • 4Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human tropboblast invasion. Reprod Biol Endo- crinol 2004; 2: 59.
  • 5Reister F, Kingdom JC, Ruck P, Marzusch K, Heyl W, Pauer U, Kaufmann P, Rath W, Huppertz B. Altered protease ex- pression by periarterial trophoblast cells in severe early-on- set preeclampsia with IUGR. J Pefinat Med 2006; 34(4): 272-279.
  • 6Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV. First-trimester serum levels of soluble endo- glin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsea. Am J Obstet Gynecol 2008; 199(3): 266.el-266.e6.
  • 7Farina A, Sekizawa A, De Sanctis P, Purwosunu Y, Okai T, Cha DH, Kang JH, Vicenzi C, Tempesta A, Wibowo N, Val- vassori L, Rizzo N. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to de- velop preeclampsia. Prenat Diagn 2008; 28(10): 956-961.

共引文献2

同被引文献11

引证文献1

二级引证文献5

中国优生与遗传杂志
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部